This study delineates a panel of transcriptionally and serologically validated biomarkers, RFC2, HSP90AB1, and YWHAZ (upregulated), and CYP2E1 and ADH4 (downregulated), that reflect core pathological processes in HCC. The gene discussed is ADH4; the disease is hepatocellular carcinoma.